Literature DB >> 24468936

Gout treatment: when a tablet is not enough.

Bonifacio Alvarez-Lario1, José L Alonso-Valdivielso1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24468936     DOI： 10.1038/nrrheum.2013.173-c1

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  11 in total

1.  Crystal arthritis: Environment and genetics in gout: a maze for clinicians?

Authors:  Fernando Perez-Ruiz; Ana María Herrero-Beites
Journal:  Nat Rev Rheumatol       Date:  2013-11-12       Impact factor: 20.543

Review 2.  Uric acid as a danger signal in gout and its comorbidities.

Authors:  Kenneth L Rock; Hiroshi Kataoka; Jiann-Jyh Lai
Journal:  Nat Rev Rheumatol       Date:  2012-09-04       Impact factor: 20.543

3.  2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Authors:  Dinesh Khanna; John D Fitzgerald; Puja P Khanna; Sangmee Bae; Manjit K Singh; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

4.  Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study.

Authors:  P H Dessein; E A Shipton; A E Stanwix; B I Joffe; J Ramokgadi
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

Review 5.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

6.  The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial.

Authors:  Yanyan Zhu; Yuqing Zhang; Hyon K Choi
Journal:  Rheumatology (Oxford)       Date:  2010-08-30       Impact factor: 7.580

7.  Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study.

Authors:  Frances Rees; Wendy Jenkins; M Doherty
Journal:  Ann Rheum Dis       Date:  2012-06-07       Impact factor: 19.103

8.  Achieving treat to target in gout: a clinical practice improvement project.

Authors:  A Y N Lim; L Shen; C H Tan; A Lateef; T C Lau; G G Teng
Journal:  Scand J Rheumatol       Date:  2012-07-28       Impact factor: 3.641

Review 9.  A perspective on diet and gout.

Authors:  Eyal Kedar; Peter A Simkin
Journal:  Adv Chronic Kidney Dis       Date:  2012-11       Impact factor: 3.620

Review 10.  A prescription for lifestyle change in patients with hyperuricemia and gout.

Authors:  Hyon K Choi
Journal:  Curr Opin Rheumatol       Date:  2010-03       Impact factor: 5.006
View more
  1 in total

1.  Reply: Gout treatment--more tablets might be needed.

Authors:  Fernando Perez-Ruiz; Ana Maria Herrero-Beites
Journal:  Nat Rev Rheumatol       Date:  2014-01-28       Impact factor: 20.543
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.